Medicskin Holdings Limited (8307.HK)
- Previous Close
0.160 - Open
0.168 - Bid --
- Ask 0.187 x --
- Day's Range
0.168 - 0.168 - 52 Week Range
0.092 - 0.222 - Volume
8,000 - Avg. Volume
620 - Market Cap (intraday)
66.652M - Beta (5Y Monthly) 0.17
- PE Ratio (TTM)
-- - EPS (TTM)
-0.010 - Earnings Date Feb 14, 2025 - Feb 17, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Jul 5, 2021
- 1y Target Est
--
Medicskin Holdings Limited, an investment holding company, provides medical skin care services in Hong Kong. The company operates Medicskin centers, which provides various medical skin care services for the treatment of skin diseases and problems, such as acne, pigmentation, rosacea, dermatitis, eczema, and warts, as well as improvement of appearance through inter alia, skin rejuvenation, facial sculpturing, and body contouring treatments; and treatment of acne scars and enlarged pores, removal of undesirable naevi, and hair removal. It provides medical consultancy services. In addition, the company engages in the sale of skincare products and medical skincare services. Further, it provides prevention healthcare services; body care and men care services, as well as offer mediskin vaccination. Medicskin Holdings Limited was founded in 2000 and is headquartered in Sheung Wan, Hong Kong. The company is a subsidiary of Topline Worldwide Limited.
www.medicskin.comRecent News: 8307.HK
View MorePerformance Overview: 8307.HK
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 8307.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 8307.HK
View MoreValuation Measures
Market Cap
66.65M
Enterprise Value
71.55M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.42
Price/Book (mrq)
7.48
Enterprise Value/Revenue
1.53
Enterprise Value/EBITDA
10.64
Financial Highlights
Profitability and Income Statement
Profit Margin
-6.22%
Return on Assets (ttm)
-5.01%
Return on Equity (ttm)
-41.11%
Revenue (ttm)
47.56M
Net Income Avi to Common (ttm)
-2.96M
Diluted EPS (ttm)
-0.010
Balance Sheet and Cash Flow
Total Cash (mrq)
12.94M
Total Debt/Equity (mrq)
322.36%
Levered Free Cash Flow (ttm)
7.51M